Proving Consistency Across our Menu
As the number of available SARS-CoV-2 antibody tests continues to increase it is now even more difficult to compare their performance. Each new test is released by testing unique specimens leaving it to the laboratory to decide how the performance of the new test compares to another test. ZEUS has completed extensive performance testing of all 3 of our devices using the same 3 cohorts (total n=365) of clinically characterized patient samples. The study allows for direct comparison of our entire menu of SARS-CoV-2 antibody tests and provides confidence to the laboratory in each of our 3 tests.
The results demonstrate a high degree of positive and negative agreement as well as low susceptibility to cross reactivity from antibodies against other respiratory pathogens for all 3 of our tests.
ZEUS Scientific has been developing in vitro diagnostic assays for over 40 years and understands there is a patient behind every result, and all results matter regardless of the method or test. ZEUS has proven consistency and accuracy in SARS-CoV-2 antibody testing.